Cyclospora is basically an intestinal ailment that is affected via the microscopic parasite termed as “Cyclospora cayetanensis”. Cyclospora Diagnostic Testing Market size on the basis of end-users spans commercial or private laboratories, hospitals, public health labs and physician offices. It is a single-celled coccidian parasitic pathogen that triggers intestinal infection that leads to diarrhea. When we look at it in the medical terms, this diarrheal infection is labeled as cyclospora infection (cyclosporiasis). It is known that this particular infection is usually spread and communicated via feces and ingestion of food and water infected with sporulated oocysts.
Through studies, it has
been found that people can be infected with Cyclospora by taking in food or
water that is polluted and tainted with the parasite. Those people are at great
risk for infection that stay in those countries or travel to regions where
cyclosporiasis is quite prevalent. It is said that cyclospora diagnostic
testing is not a regular laboratory test. It is only taken up following exact
and particular requests from specialized physicians and doctors.
Get Free PDF Sample (Including Full TOC,
List of Tables & Figures) @ https://www.millioninsights.com/industry-reports/cyclospora-diagnostic-testing-market/request-sample
The most fundamental
laboratory tests that are carried out for Cyclospora entail acid-fast staining
and safranin staining. Even though there are a wide range of tests available,
it is quite fascinating to know that there are no blood tests available for the
treatment of Cyclospora infection. The prominent factors that are playing a
major role in raising the demand for cyclospora diagnostic testing include
augmented modernization, improvement in technology, and rising concerns for
health related issues. Cyclospora Diagnostic
Testing Market size on the basis of techniques used for diagnosis spans
chromatography, diagnostic imaging, gel microdroplets, immunoassays, liposomal
testing, differential light scattering, flow cytometry, monoclonal antibodies,
and molecular diagnostics.
Cyclospora Diagnostic
Testing Market size on the basis of geography spans North America, Asia
Pacific, Europe, and Rest of the World. As far as the geography is concerned,
Asia Pacific is lately dominating the Cyclospora Diagnostic Testing market and
it is also recognized as the largest market for these tests owing to more
susceptive surrounding for infection. The data shows that this particular
disease is quite prevalent in tropical and subtropical countries of Latin
America and Asia.
In addition, latest
irregular occurrence of the infection has also been observed in temperate
countries including the U.S., Canada, and Mexico. The data that has been
revealed from the studies of the Centers for Disease Control and Prevention
states that above 600 cases of Cyclospora infection were witnessed in 2013,
because of the infection communicated via the means of packaged salad mix. The
key players operating in the cyclospora diagnostic testing market include Roche
Diagnostics, Siemens Healthcare, Diamedix Corporation, Hologic, Inc., DiaSorin
S.p.A., Thermo Fisher Scientific, Inc., QIAGEN N.V., Wako Chemicals, Inc,
Affymetrix, Inc., Nanogen, Inc., Ortho Clinical Diagnostics, Beckman Coulter,
Inc., bioMerieux, Inc., and CEPHEID.
Know More Insights
@ https://newsonmarketblog.wordpress.com
No comments:
Post a Comment